Once-daily aminoglycoside therapy: potential ototoxicity.
Current data indicate that once-daily aminoglycoside therapy is as efficacious as traditional multiple daily dosing and equally or less toxic. Our experience with once-daily gentamicin, 6 mg/kg of body weight led to a 10% (3 of 33 patients) occurrence of documented ototoxicity after prolonged aminog...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1996
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163502/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8878610/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.9.2209 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|